The The Hematology, ASH Education Program (Hematology 2025) is an annual publication that provides practicing hematologists with invaluable information on the most important areas of clinical progress.

Hematology 2025 is a peer-reviewed collection of articles written by the 2025 ASH Education Program speakers and the Ham-Wasserman Lecturer. The papers showcase groundbreaking advances and new concepts in 30 different fields. Every year, the periodical provides an updated and comprehensive review of each of the topics covered in the annual meeting education sessions. The publication is supplemented by two online knowledge tests based on the articles from each edition.

Educational Objectives

1. Employ the knowledge gained regarding the diagnosis and treatment of malignant and classical hematologic disorders to improve patient care.
2. Discuss state-of-the-art therapeutics in hematology.
3. Analyze the potential contribution of novel, not-yet-approved modalities of therapy to current evidence-based management of malignant and classical hematologic disorders.

Date of Release

December 2025

Date of Expiration

On December 31, 2026, the ability to earn Continuing Medical Education (CME) credit and American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points for this product expires. This is the last date for learners to claim credit for this product. For questions about credit, please contact the ASH Education Department at cme@hematology.org or call 866-828-1231 (toll-free) within the United States only or 1-202-776-0544 internationally.

Hematology 2025 Planner and Editor Disclaimers

Review Hematology 2025 Planner and Editor Disclosures at Relevant Financial Relationships

Commercial Support

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, GlaxoSmithKline LLC, Merck Sharp & Dohme Corporation, and Novartis Pharmaceuticals Corporation.